The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated interim analysis of the randomized phase 1b/3 study of tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma.
 
Connie Lee Batlevi
Stock and Other Ownership Interests - Bristol-Myers Squibb; Moderna Therapeutics; Novavax; Pfizer; Regeneron; Viatris
Honoraria - Dava Oncology
Consulting or Advisory Role - Celgene; Gerson Lehrman Group; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Lifesci Capital; Seagen; TG Therapeutics
Research Funding - Autolus (Inst); Bayer (Inst); Epizyme (Inst); Janssen Biotech (Inst); Novartis (Inst); Roche (Inst); Xynomic Pharma (Inst)
 
Steven I. Park
Consulting or Advisory Role - G1 Therapeutics; Rafael Pharmaceuticals; Teva
Speakers' Bureau - Gilead Sciences; Seagen
Research Funding - Bristol-Myers Squibb; Seagen
 
Tycel Jovelle Phillips
Honoraria - Lymphoma & Myeloma Connect; Seagen
Consulting or Advisory Role - ADC Therapeutics; Bayer; Celgene; Curis; Genentech; Genmab; Gilead Sciences; Incyte; Kite/Gilead; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - Abbvie; Bayer; Pharmacyclics/Janssen
 
Jennifer Amengual
Speakers' Bureau - Daiichi Sankyo
Research Funding - Appia Pharmaceuticals
 
David Jacob Andorsky
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Bristol-Myers Squibb/Celgene
Research Funding - Abbvie; Bristol-Myers Squibb/Celgene; Epizyme; TG Therapeutics
 
Philip Campbell
Consulting or Advisory Role - Amgen; AstraZeneca; CSL Behring; Janssen; Novartis; Roche
Research Funding - Amgen; Celgene/Bristol-Myers Squibb; Janssen; Novartis; Roche
 
Pamela McKay
Leadership - BeiGene; Celgene; Gilead Sciences; Janssen; Roche; Takeda
Honoraria - Gilead Sciences; Janssen; Roche; Takeda
 
John Paul Leonard
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Akcea Therapeutics; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Epizyme; Genentech/Roche; Genmab; Gilead Sciences; Incyte; Janssen Oncology; Karyopharm Therapeutics; MEI Pharma; Merck; Miltenyi Biotec; Morphosys; MustangBio; Nordic Nanovector; Nordic Nanovector; Regeneron; Sandoz; Second Genome; Sutro Biopharma
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Celgene (Inst); Epizyme (Inst); Genentech (Inst); Janssen Oncology (Inst); National Cancer Institute (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BeiGene
 
Manu Sondhi
Employment - Epizyme
 
Jay Yang
Employment - Epizyme
 
Yingxue Chen
Employment - Epizyme
 
Heather O'Connor
Employment - Epizyme
 
Pamela Slatcher
Employment - Epizyme
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER
Expert Testimony - Roche/Genentech